SB1230

Marijuana; clinical research trials

Chamber Passed·3/5/25

Arizona SB1230 amends medical marijuana laws to fund clinical research trials and other public health initiatives.

Arizona SB1230 amends sections 36-2817 and 36-2822 of the Arizona Revised Statutes to establish the medical marijuana fund, which collects fees, penalties, and donations. The fund's monies are used to provide grants for marijuana clinical trials approved by the FDA, focusing on safety, efficacy, and drug interactions. The Arizona biomedical research centre will provide up to $5,000,000 annually for five years for these trials.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the Senate · 0–0 · Mar 5, 2025
Current
The House
Next
Session adjourned — paused until it reconvenes

Sponsors

0
1
R
Democratic CaucusRepublican Caucus

Roll Call Votes

Passed

Calendar

Apr 14, 2025

1:00 PM

House Rules

Mar 31, 2025

10:00 AM

House Appropriations

History

Jun 4, 2025

House

House third reading FAILED voting: (13-39-8-0)

Jun 4, 2025

House

House motion to reconsider third reading

Apr 22, 2025

House

House Committee of the Whole action: Do Pass Amended